LNG Market Forecast: Steady Growth at 4-6% Yearly for Next Decade

被引：0
|
作者：
机构：
来源：
Propane Can. | / 1卷 / 13-14期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 22 条
  • [21] The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance
    Lawson, Mandy
    Cureton, Natalie
    Ros, Susana
    Cheraghchi-Bashi, Azadeh
    Urosevic, Jelena
    D'Arcy, Sophie
    Delpuech, Oona
    Dupont, Michelle
    Fisher, David I.
    Gangl, Eric T.
    Lewis, Hilary
    Trueman, Dawn
    Wali, Neha
    Williamson, Stuart C.
    Moss, Jennifer
    Montaudon, Elodie
    Derrien, Heloise
    Marangoni, Elisabetta
    Miragaia, Ricardo J.
    Gagrica, Sladjana
    Morentin-Gutierrez, Pablo
    Moss, Thomas A.
    Maglennon, Gareth
    Sutton, Daniel
    Polanski, Radoslaw
    Rosen, Alan
    Cairns, Jonathan
    Zhang, Pei
    Sanchez-Guixe, Monica
    Serra, Violeta
    Critchlow, Susan E.
    Scott, James S.
    Lindemann, Justin P. O.
    Barry, Simon T.
    Klinowska, Teresa
    Morrow, Christopher J.
    Carnevalli, Larissa
    CANCER RESEARCH, 2023, 83 (23) : 3989 - 4004
  • [22] Next-generation sequencing (NGS) results among hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC) patients treated with a CDK4 & 6 inhibitor: A retrospective observational study based on real-world data.
    Hamilton, Erika Paige
    Jansen, Valerie Malyvanh
    Smyth, Emily Nash Nash
    Schlauch, Daniel
    Carter, Gebra Cuyun
    Willard, Melinda D.
    Misch, Amanda
    Bowman, Lee
    Zhu, Yajun Emily
    McNeely, Samuel
    Lin, Aimee Bence
    Picard, Shaita
    Blackwell, Kimberly
    Burris, Howard A.
    Spigel, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
123